Research Article
Factors Associated with RANTES Concentration in Cardiovascular Disease Patients
Table 2
Laboratory parameters of cardiovascular disease patients compared to control group. Results are presented as median and interquartiles.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMI: acute myocardial infarction, eGFR: estimated glomerular filtration rate, F: female, hsCRP: high sensitivity C-reactive protein, M: male, MPV: mean platelet volume, N: number of individuals, NS: not statistically significant, NSTEMI: non-ST elevation myocardial infarction, PLT: platelet count, SA: stable angina, STEMI: ST elevation myocardial infarction, TG: triglycerides, WBC: white blood cells count. Conversion factors to SI units are as follows: for WBC: 1.0, for total cholesterol: 0.0259, for LDL-cholesterol: 0.0259, for HDL-cholesterol: 0.0259, for TG: 0.0114, for glucose: 0.0555, for creatinine: 88.402. |